Journal of pharmacopuncture · 2017 · 60 citations · 21 references
Life SciencesImmunologyPharmacologyAutoimmunityInflammationInnate ImmunityAnti-inflammatory PharmacologyInflammation In Infectious DiseaseInflammation PharmacologyInflammatory Cell ResponsesInflammatory MediatorsNeutrophil BiologyAnti-inflammatory ActivityAnti-inflammatory TherapeuticsNeutrophil Function ModulationNeutrophil PhysiologyNeutrophil-mediated DamageNeutrophil-mediated InflammationNeutrophil-mediated InjuryPro-inflammatory Mediator Production
OBJECTIVES: productions and MPO activity in human neutrophils were investigated. METHODS: , NO and MPO productions were analyzed using enzyme-linked immunosorbent assay (ELISA), Griess Reagent, and MPO assay kits, respectively. Also, the viability of human neutrophils was assessed using tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), and neutrophils were treated with various concentrations of rutin (1 - 100 μM), after which MTT was appended and incubated at 37ºC for 4 hour. RESULTS: < 0.001). CONCLUSION: productions, as well as MPO activity, in activated human neutrophils. Treatment with rutin may be considered as a therapeutic strategy for neutrophil-mediated inflammatory/ autoimmune diseases.
21
Aihao Ding, Carl Nathan, Dennis J. Stuehr · The Journal of Immunology · 1988 · 2.8K citations · Full text